Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
ENTITY
Oryzon Genomics (ORY SM)
Watchlist
58
Analysis
Health Care
•
Spain
Oryzon Genomics, SA is a clinical stage biopharmaceutical company that develops epigenetics-based therapeutics.
more
Watchlist
All
Insights
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bullish
•
Oryzon Genomics
•
14 Mar 2023 15:38
•
Issuer-paid
Oryzon Genomics - New clinical candidate expands CNS portfolio
Oryzon Genomics has nominated a new central nervous system (CNS) clinical development candidate, ORY-4001, for the treatment of rare CNS disorders...
Edison Investment Research
Follow
219 Views
Share
bullish
•
Oryzon Genomics
•
06 Mar 2023 23:34
•
Issuer-paid
Oryzon Genomics - Catalysts on the horizon in FY23
FY23 is shaping up to be a busy clinical year for Oryzon with readouts and trial initiations expected across its lead assets. The next major...
Edison Investment Research
Follow
236 Views
Share
bullish
•
Oryzon Genomics
•
28 Feb 2023 20:36
•
Issuer-paid
Oryzon Genomics - KOL event puts near-term catalysts in the spotlight
At Oryzon’s recent key opinion leader (KOL) event, management elaborated on the near-term clinical catalysts for its lead assets iadademstat, in...
Edison Investment Research
Follow
195 Views
Share
bullish
•
Oryzon Genomics
•
21 Feb 2023 15:06
•
Issuer-paid
Oryzon Genomics - Progress in oncology and CNS in FY22
Oryzon Genomics has presented headline FY22 financial results, which reflect continued progress on its clinical activities for key assets...
Edison Investment Research
Follow
212 Views
Share
bullish
•
Oryzon Genomics
•
19 Jan 2023 00:20
•
Issuer-paid
Oryzon Genomics - First Phase II patient enrolled is clinical milestone
Oryzon Genomics has announced that it has enrolled the first patient into its collaborative Phase II trial investigating the use of its lead LSD1...
Edison Investment Research
Follow
198 Views
Share
First
Previous
3
4
5
6
7
8
9
Next
Last
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.40.5
x